Early-stage classical Hodgkin lymphoma in children and adolescents: when can radiotherapy be safely omitted?
- PMID: 36858717
- DOI: 10.1016/S1470-2045(23)00058-X
Early-stage classical Hodgkin lymphoma in children and adolescents: when can radiotherapy be safely omitted?
Conflict of interest statement
I declare no competing interests. I am involved in the European Network for Paediatric Hodgkin Lymphoma, but I had no part in the Euronet-PHL-C1 trial.
Comment on
-
Response-adapted omission of radiotherapy in children and adolescents with early-stage classical Hodgkin lymphoma and an adequate response to vincristine, etoposide, prednisone, and doxorubicin (EuroNet-PHL-C1): a titration study.Lancet Oncol. 2023 Mar;24(3):252-261. doi: 10.1016/S1470-2045(23)00019-0. Lancet Oncol. 2023. PMID: 36858722 Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
